JACC. Cardiovascular interventions

publication venue for

Left Main Coronary Trunk Compression by a Severely Enlarged Pulmonary Artery: Noninvasive and Invasive Assessment. 2018
Inter-Rater Reliability for the Amputation Endpoint in the National Vascular Quality Initiative.. 17. 2024
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial.. 16. 2023
First Report of Visualization of Z-Shape Phenomenon by Optical Coherence Tomography.. 16. 2023
Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.. 16. 2023
Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial.. 16. 2023
Contrast-Induced Encephalopathy After Diagnostic Coronary Angiography: Rare Condition That Mimics Stroke.. 16. 2023
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.. 16. 2023
Positive Nuclear Stress Test After STEMI: Importance of Invasive Physiologic Assessment and Acetylcholine Testing.. 16. 2023
Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions.. 16. 2023
Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada. 2022
Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality.. 15. 2022
Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score.. 15. 2022
Prospective Multicenter Trial of Pharmacomechanical-Catheter-Directed Thrombolysis with the Bashir Endovascular Catheter for Acute Pulmonary Embolism. 2022
Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.. 15. 2022
Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention.. 15. 2022
Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States.. 15. 2022
Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. 2022
Multiphase Assessment of Mitral Annular Dynamics in Consecutive Patients With Significant Mitral Valve Disease. 2021
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes.. 14. 2021
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes.. 14. 2021
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes.. 14. 2021
"Matryoshka" Valve-in-Valve-in-Valve Transcatheter Aortic Valve Replacement and Do-It-Yourself Catheter to Cross Aortic Valve Bioprosthesis Stenosis.. 14. 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES.. 14. 2021
Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial.. 14. 2021
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes.. 14. 2021
Contemporary Transcatheter Mitral Valve Replacement for Mitral Annular Calcification or Ring.. 13. 2020
Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials.. 13. 2020
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation.. 13. 2020
BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials.. 13. 2020
The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation.. 13. 2020
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.. 13. 2020
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft.. 13. 2020
Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort.. 13. 2020
Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve.. 13. 2019
Unilateral Access Is Safe and Facilitates Peripheral Bailout During Transfemoral-Approach Transcatheter Aortic Valve Replacement.. 12. 2019
Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease.. 12. 2019
The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials.. 12. 2019
Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.. 12. 2019
The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.. 12. 2019
Diagnostic Value of 3-Dimensional Vena Contracta Area for the Quantification of Residual Mitral Regurgitation After MitraClip Procedure.. 12. 2019
Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry.. 12. 2019
Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training.. 12. 2019
Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.. 12. 2018
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.. 11. 2018
Contemporary Trends and Comparative Outcomes With Adjunctive Inferior Vena Cava Filter Placement in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis in the United States: Insights From the National Inpatient Sample.. 11. 2018
Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST Substudy.. 11. 2018
Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve.. 11. 2018
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.. 11. 2018
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.. 11. 2018
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.. 11. 2018
Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.. 11. 2018
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial.. 11. 2018
The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.. 10. 2017
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.. 10. 2017
Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions and Association With Procedural Outcomes.. 10. 2017
Comparison of Trends and In-Hospital Outcomes of Concurrent Carotid Artery Revascularization and Coronary Artery Bypass Graft Surgery: The United States Experience 2004 to 2012.. 10. 2017
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.. 10. 2017
Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.. 10. 2017
The Influence of Lesion Location on the Diagnostic Accuracy of Adenosine-Free Coronary Pressure Wire Measurements.. 9. 2016
Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention.. 9. 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.. 9. 2016
Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study.. 9. 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.. 9. 2016
Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device.. 9. 2016
3D Printed Modeling for Patient-Specific Mitral Valve Intervention: Repair With a Clip and a Plug.. 9. 2016
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.. 9. 2016
Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials.. 9. 2016
Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).. 8. 2015
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.. 8. 2015
Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.. 8. 2015
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.. 8. 2015
Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).. 8. 2015
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.. 8. 2015
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial).. 8. 2015
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.. 7. 2014
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.. 7. 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.. 7. 2014
Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.. 7. 2014
Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction).. 7. 2014
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.. 7. 2014
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).. 6. 2013
Prognostic significance of bleeding location and severity among patients with acute coronary syndromes.. 6. 2013
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.. 6. 2013
Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial.. 6. 2013
Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.. 6. 2012
Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.. 5. 2012
Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis.. 5. 2012
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.. 5. 2012
Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis.. 5. 2012
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.. 3. 2010
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.. 2. 2009
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.. 2. 2009
A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).. 2. 2009
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.. 2. 2009
Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.. 2. 2009
Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.. 2. 2009
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.. 2. 2009
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.. 2. 2009
Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007.. 1. 2008
Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction.. 1. 2008
Reply: Fractional Flow Reserve-Guided Coronary Artery Bypass Surgery: More Evidence Required to Say Less Is More.. 13. 2020
Reply: The Spotlight Is on Secondary Access for TAVR: Radial Versus Femoral Revisited.. 13. 2020
FFR Cutoff by Arterial Graft Configuration and Location: IMPAG Trial Insights.. 13. 2020
The Impact of Hospital Characteristics on the Outcomes of Interventional Cardiac Procedures.. 12. 2019
Association of a Novel Hemodynamic Index With Aortic Regurgitation After TAVR With the Edwards SAPIEN Valve.. 12. 2019
Reply: Bashir Catheter-Directed Thrombolysis for Acute Pulmonary Embolism. 2022
Functional Mitral Regurgitation Staging and its Relationship to Outcomes in the COAPT Trial. 2022
Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies. 2022
Risk Assessment of Coronary Artery Obstruction Following Valve-in-Valve TAVR Using Dual IVUS Ostial Evaluation Technique. 2021
Reply: Aspiration Thrombectomy in Intermediate-High Risk Pulmonary Embolism Patients: More Work Ahead. 2021
Reply: Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism. 2021
Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study. 2020
Reply: Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO? 2019
Morphological Patterns of In-Stent Chronic Total Occlusions: An Intravascular Ultrasound Study. 2018
Reply: Treatment Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is Staged PCI Truly the Best Option? 2017
Reply: relationship between myocardial reperfusion, infarct size, and mortality. 2013
Is it Time to Sunset Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive PE?. 14. 2021
Atherectomy in Peripheral Vascular Interventions: Time to Follow the Guidelines?. 14. 2021
Atrial Septal Defect: Transcatheter Closure Is Not Bad, But There Is More to the Story.. 14. 2021
Sex Differences in Coronary Microvascular Dysfunction and Its Relationship With Outcome.. 13. 2020
At the Intersection of Logic and Statistics: Is Proximal Left Anterior Descending Artery Revascularization Still a Notable Event?. 13. 2020
The DAPT Score Uncouples Bleeding and Ischemic Risk…Again.. 13. 2020
One Size Does Not Fit All: Improving Recruitment and Retention of Women in Cardiovascular Device-Related Clinical Trials.. 12. 2019
Simultaneous Anatomic and Physiologic Assessment of Coronary Artery Disease With Coronary Angiography Alone: Seeing the Future.. 12. 2019
The Era of Drug-Coated Balloons: Are All Created Equal?. 11. 2018
Predicting Outcomes After Percutaneous Coronary Intervention Using Relative Change in Fractional Flow Reserve.. 11. 2018
Disarming the Ticking Time Bomb: Post-Procedure Electrocardiography Predictors of High-Degree Conduction Disturbances After Transcatheter Aortic Valve Replacement.. 11. 2018
The OPTALYSE PE Trial: Another Step Toward Understanding the Truth About Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.. 11. 2018
Whose Urgency Is it, Anyway?. 11. 2018
Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk of Stroke After Coronary Stenting.. 11. 2018
The Impact of IMPACT-Contemporary Outcomes With Balloon Aortic Valvuloplasty: Are We Doing the Right Thing?. 10. 2017
Stent Selection in the Iliac Arteries: Don't Fall Through the ICE!. 10. 2017
New Approach to Intervention on Blalock-Taussig Shunts.. 10. 2017
More Bad News for Patients With Diabetes and a Thin Silver Lining.. 10. 2017
The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients.. 9. 2016
Invasive Assessment of the Coronary Microcirculation.. 9. 2016
Transcatheter Versus Surgical Closure of Atrial Septal Defects.. 9. 2016
Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand?. 8. 2015
Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.. 3. 2010
Antithrombin therapy for elective percutaneous coronary intervention: which agent to use? Does it matter?. 2. 2009
Patent foramen ovale: closing arguments.. 2. 2009
Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR. 2023
Impact of Surgical and Transcatheter Aortic Valve Replacement in Low-Gradient Aortic Stenosis: A Meta-Analysis. 2021
Superior Vena Cava Syndrome. 2021
Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 Trials. 2021
Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure. 2019
The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. 2017
PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI: Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Disease. 2023
SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure. 2023

VIVO Weill Cornell Medical College

JACC. Cardiovascular interventions Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

Electronic International Standard Serial Number (EISSN)